Assembly Biosciences, Inc.
ASMB
$30.82
$0.411.35%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 153.52% | 31.30% | 54.77% | 148.33% | 298.16% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 153.52% | 31.30% | 54.77% | 148.33% | 298.16% |
| Cost of Revenue | 15.88% | 17.44% | 17.62% | 27.41% | 14.38% |
| Gross Profit | 127.32% | -1.31% | 10.40% | 19.63% | 34.32% |
| SG&A Expenses | 8.89% | -14.97% | -18.35% | -20.64% | -21.40% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 14.18% | 7.86% | 6.61% | 11.67% | 2.97% |
| Operating Income | 73.32% | 6.44% | 13.87% | 20.04% | 29.74% |
| Income Before Tax | 84.64% | 4.32% | 13.57% | 22.86% | 34.89% |
| Income Tax Expenses | -- | -117.31% | -117.31% | 900.00% | 900.00% |
| Earnings from Continuing Operations | 84.76% | 5.53% | 14.57% | 22.27% | 34.38% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 84.76% | 5.53% | 14.57% | 22.27% | 34.38% |
| EBIT | 73.32% | 6.44% | 13.87% | 20.04% | 29.74% |
| EBITDA | 73.53% | 6.35% | 13.68% | 19.76% | 29.45% |
| EPS Basic | 71.34% | 33.20% | 37.64% | 42.63% | 50.86% |
| Normalized Basic EPS | 71.09% | 32.30% | 36.97% | 43.15% | 51.28% |
| EPS Diluted | 71.34% | 33.20% | 37.64% | 42.63% | 50.86% |
| Normalized Diluted EPS | 71.09% | 32.30% | 36.97% | 43.15% | 51.28% |
| Average Basic Shares Outstanding | 86.51% | 50.81% | 34.67% | 33.24% | 31.16% |
| Average Diluted Shares Outstanding | 86.51% | 50.81% | 34.67% | 33.24% | 31.16% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |